Two-quadrant anaesthesia technique reduces pain during vitrectomy

Article

Using two-quadrant sub-Tenon's anaesthesia is more effective at reducing intraoperative and postoperative pain than a single-quadrant technique.

Using two-quadrant sub-Tenon's anaesthesia is more effective at reducing intraoperative and postoperative pain than a single-quadrant technique, states a study in the British Journal of Ophthalmology.

Dr Vip S. Gill et al., Department of Anaesthesia, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK, studied 54 patients undergoing vitrectomy. All patients were equally randomized into two groups.

Group A, the control, were administered a standard 5 ml single inferonasal sub-Tenon injection of 2% lidocaine and 0.5% bupivacaine in a 50:50 mixture. Group B, the study group, received a 5 ml inferonasal and 5 ml superotemporal injection.

Primary outcome measures included amount of intraoperative top-ups needed and the secondary outcome measures included intraoperative and postoperative pain scores, IOP, block onset time, ocular akinesia, eyelid akinesia and chemosis.

In the group V there were no patients requiring an anaesthetic top-up, but in the control group a top-up was needed in 24 patients. In group B block onset was shorter, eyelid akinesia was improved and pain scores were reduced intraoperatively and 0–2 hours (h), 4–6 h, 10–14 h and 20–24 h postoperatively.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.